<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med</journal-id><journal-id journal-id-type="iso-abbrev">BMC Med</journal-id><journal-title-group><journal-title>BMC Medicine</journal-title></journal-title-group><issn pub-type="epub">1741-7015</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3820155</article-id><article-id pub-id-type="publisher-id">1741-7015-11-193</article-id><article-id pub-id-type="doi">10.1186/1741-7015-11-193</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Dapagliflozin add-on to metformin in type 2 diabetes inadequately
controlled with metformin: a randomized, double-blind, placebo-controlled 102-week
trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Bailey</surname><given-names>Clifford J</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>c.j.bailey@aston.ac.uk</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Gross</surname><given-names>Jorge L</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>jorgeluizgross@gmail.com</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Hennicken</surname><given-names>Delphine</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>delphine.hennicken@bms.com</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Iqbal</surname><given-names>Nayyar</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>nayyar.iqbal@bms.com</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Mansfield</surname><given-names>Traci A</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>traci.mansfield@bms.com</email></contrib><contrib contrib-type="author" id="A6"><name><surname>List</surname><given-names>James F</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>james.list@bms.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Life and Health Sciences, Aston University, Birmingham B4 7ET, UK</aff><aff id="I2"><label>2</label>Endocrine Division, Universidade Federal do Rio Grande do Sul, Avenida Paulo Gama
110-Reitoria, Porto Alegre 90040-060, Brazil</aff><aff id="I3"><label>3</label>Global Biometric Services, Bristol-Myers Squibb, Parc de l&#x02019;Alliance, Avenue
de Finlande 4, Braine I&#x02019;Alleud B-1420, Belgium</aff><aff id="I4"><label>4</label>Global Clinical Research, Bristol-Myers Squibb, Route 206 &#x00026; Province Line
Road, Princeton, NJ 08543, USA</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>2</day><month>9</month><year>2013</year></pub-date><volume>11</volume><fpage>193</fpage><lpage>193</lpage><history><date date-type="received"><day>20</day><month>8</month><year>2013</year></date><date date-type="accepted"><day>20</day><month>8</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Bailey et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Bailey et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which
permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1741-7015/11/193"/><related-article related-article-type="corrected-article" id="d33e6" vol="11" page="43" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="23425012" ext-link-type="pubmed"/></article-meta></front><body><sec><title>Correction</title><p>The authors [<xref ref-type="bibr" rid="B1">1</xref>] note that the standard errors in
Table 3 (Table&#x000a0;<xref ref-type="table" rid="T1">1</xref> here) are actually standard deviations. The
reference to standard errors in the footnote has now been edited accordingly.</p><p>This is a Correction article on
<ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1741-7015/11/43">http://www.biomedcentral.com/1741-7015/11/43</ext-link>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Summary of laboratory parameters</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="left">&#x000a0;</th><th align="center"><bold>PBO + MET (n = 137)</bold></th><th align="center"><bold>DAPA 2.5 mg + MET (n = 137)</bold></th><th align="center"><bold>DAPA 5 mg + MET (n = 137)</bold></th><th align="center"><bold>DAPA 10 mg + MET (n = 135)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><bold>Sodium (mmol/L)</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">n<hr/></td><td align="center" valign="bottom">72<hr/></td><td align="center" valign="bottom">77<hr/></td><td align="center" valign="bottom">87<hr/></td><td align="center" valign="bottom">93<hr/></td></tr><tr><td align="left" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">138.9 (2.3)<hr/></td><td align="center" valign="bottom">138.5 (2.9)<hr/></td><td align="center" valign="bottom">138.6 (2.3)<hr/></td><td align="center" valign="bottom">139.1 (2.2)<hr/></td></tr><tr><td align="left" valign="bottom">Change at week 102<hr/></td><td align="center" valign="bottom">-0.04 (2.7)<hr/></td><td align="center" valign="bottom">0.2 (2.8)<hr/></td><td align="center" valign="bottom">0.1 (2.6)<hr/></td><td align="center" valign="bottom">0.1 (2.6)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>P</italic> vs PBO + MET<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.1434<hr/></td><td align="center" valign="bottom">0.1905<hr/></td><td align="center" valign="bottom">0.3978<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Potassium (mmol/L)</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">n<hr/></td><td align="center" valign="bottom">72<hr/></td><td align="center" valign="bottom">77<hr/></td><td align="center" valign="bottom">87<hr/></td><td align="center" valign="bottom">93<hr/></td></tr><tr><td align="left" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">4.35 (0.47)<hr/></td><td align="center" valign="bottom">4.34 (0.46)<hr/></td><td align="center" valign="bottom">4.37 (0.39)<hr/></td><td align="center" valign="bottom">4.37 (0.43)<hr/></td></tr><tr><td align="left" valign="bottom">Change at week 102<hr/></td><td align="center" valign="bottom">-0.08 (0.55)<hr/></td><td align="center" valign="bottom">-0.01 (0.45)<hr/></td><td align="center" valign="bottom">-0.05 (0.35)<hr/></td><td align="center" valign="bottom">-0.07 (0.47)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>P</italic>&#x02009;vs PBO + MET<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.3366<hr/></td><td align="center" valign="bottom">0.4563<hr/></td><td align="center" valign="bottom">0.9918<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Serum creatinine (&#x003bc;mol/L)</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">n<hr/></td><td align="center" valign="bottom">72<hr/></td><td align="center" valign="bottom">77<hr/></td><td align="center" valign="bottom">88<hr/></td><td align="center" valign="bottom">93<hr/></td></tr><tr><td align="left" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">76.9 (17.9)<hr/></td><td align="center" valign="bottom">78.7 (18.1)<hr/></td><td align="center" valign="bottom">79.6 (19.3)<hr/></td><td align="center" valign="bottom">77.8 (17.8)<hr/></td></tr><tr><td align="left" valign="bottom">Change at week 102<hr/></td><td align="center" valign="bottom">-0.9 (10.3)<hr/></td><td align="center" valign="bottom">-1.8 (9.7)<hr/></td><td align="center" valign="bottom">-3.5 (12.7)<hr/></td><td align="center" valign="bottom">-2.7 (10.6)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>P</italic> vs PBO + MET<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.9954<hr/></td><td align="center" valign="bottom">0.4720<hr/></td><td align="center" valign="bottom">0.9032<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Serum uric acid (&#x003bc;mol/L)</bold><sup>
<bold>a</bold>
</sup><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">n<hr/></td><td align="center" valign="bottom">28<hr/></td><td align="center" valign="bottom">35<hr/></td><td align="center" valign="bottom">47<hr/></td><td align="center" valign="bottom">57<hr/></td></tr><tr><td align="left" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">314 (79)<hr/></td><td align="center" valign="bottom">322 (80)<hr/></td><td align="center" valign="bottom">323 (88)<hr/></td><td align="center" valign="bottom">323 (80)<hr/></td></tr><tr><td align="left" valign="bottom">Change at week 102<hr/></td><td align="center" valign="bottom">-1.78 (54.13)<hr/></td><td align="center" valign="bottom">-55.9 (50.32)<hr/></td><td align="center" valign="bottom">-46.4 (64.36)<hr/></td><td align="center" valign="bottom">-52.9 (64.36)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>P</italic> vs PBO + MET<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.0054<hr/></td><td align="center" valign="bottom">0.0013<hr/></td><td align="center" valign="bottom">0.0002<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Blood urea nitrogen (mmol/L)</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">n<hr/></td><td align="center" valign="bottom">72<hr/></td><td align="center" valign="bottom">77<hr/></td><td align="center" valign="bottom">88<hr/></td><td align="center" valign="bottom">93<hr/></td></tr><tr><td align="left" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">5.33 (1.55)<hr/></td><td align="center" valign="bottom">5.51 (1.41)<hr/></td><td align="center" valign="bottom">5.65 (1.81)<hr/></td><td align="center" valign="bottom">5.34 (1.41)<hr/></td></tr><tr><td align="left" valign="bottom">Change at week 102<hr/></td><td align="center" valign="bottom">0.56 (1.24)<hr/></td><td align="center" valign="bottom">0.70 (1.54)<hr/></td><td align="center" valign="bottom">0.42 (1.87)<hr/></td><td align="center" valign="bottom">0.73 (1.44)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>P</italic>&#x02009;vs PBO + MET<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.2299<hr/></td><td align="center" valign="bottom">0.4169<hr/></td><td align="center" valign="bottom">0.0845<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Haematocrit (%)</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">n<hr/></td><td align="center" valign="bottom">71<hr/></td><td align="center" valign="bottom">78<hr/></td><td align="center" valign="bottom">87<hr/></td><td align="center" valign="bottom">93<hr/></td></tr><tr><td align="left" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">42.61 (3.90)<hr/></td><td align="center" valign="bottom">42.38 (3.99)<hr/></td><td align="center" valign="bottom">42.15 (3.59)<hr/></td><td align="center" valign="bottom">42.88 (3.95)<hr/></td></tr><tr><td align="left" valign="bottom">Change at week 102<hr/></td><td align="center" valign="bottom">-1.43 (3.29)<hr/></td><td align="center" valign="bottom">0.84 (2.53)<hr/></td><td align="center" valign="bottom">1.35 (2.48)<hr/></td><td align="center" valign="bottom">1.54 (2.78)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>P</italic> vs PBO + MET<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x0003c;0.0001<hr/></td><td align="center" valign="bottom">&#x0003c;0.0001<hr/></td><td align="center" valign="bottom">&#x0003c;0.0001<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Haemoglobin (g/L)</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">n<hr/></td><td align="center" valign="bottom">71<hr/></td><td align="center" valign="bottom">78<hr/></td><td align="center" valign="bottom">87<hr/></td><td align="center" valign="bottom">94<hr/></td></tr><tr><td align="left" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">142.8 (13.45)<hr/></td><td align="center" valign="bottom">142.5 (14.25)<hr/></td><td align="center" valign="bottom">141.6 (12.19)<hr/></td><td align="center" valign="bottom">143.6 (13.10)<hr/></td></tr><tr><td align="left" valign="bottom">Change at week 102<hr/></td><td align="center" valign="bottom">-4.9 (10.14)<hr/></td><td align="center" valign="bottom">1.5 (7.73)<hr/></td><td align="center" valign="bottom">3.1 (8.40)<hr/></td><td align="center" valign="bottom">4.1 (8.84)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>P</italic>&#x02009;vs PBO + MET<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x0003c;0.0001<hr/></td><td align="center" valign="bottom">&#x0003c;0.0001<hr/></td><td align="center" valign="bottom">&#x0003c;0.0001<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Systolic blood pressure (mm Hg)</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">n<hr/></td><td align="center" valign="bottom">72<hr/></td><td align="center" valign="bottom">78<hr/></td><td align="center" valign="bottom">88<hr/></td><td align="center" valign="bottom">94<hr/></td></tr><tr><td align="left" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">128 (15)<hr/></td><td align="center" valign="bottom">127 (14)<hr/></td><td align="center" valign="bottom">127 (14)<hr/></td><td align="center" valign="bottom">126 (16)<hr/></td></tr><tr><td align="left" valign="bottom">Change at week 102<hr/></td><td align="center" valign="bottom">1.5 (13.7)<hr/></td><td align="center" valign="bottom">0.7 (16.1)<hr/></td><td align="center" valign="bottom">-1.1 (13.2)<hr/></td><td align="center" valign="bottom">-0.3 (15.0)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>P</italic>&#x02009;vs PBO + MET<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.1111<hr/></td><td align="center" valign="bottom">0.0136<hr/></td><td align="center" valign="bottom">0.0067<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Diastolic blood pressure (mm Hg)</bold><hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">n<hr/></td><td align="center" valign="bottom">72<hr/></td><td align="center" valign="bottom">78<hr/></td><td align="center" valign="bottom">88<hr/></td><td align="center" valign="bottom">94<hr/></td></tr><tr><td align="left" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">81 (9)<hr/></td><td align="center" valign="bottom">80 (9)<hr/></td><td align="center" valign="bottom">81 (9)<hr/></td><td align="center" valign="bottom">79 (10)<hr/></td></tr><tr><td align="left" valign="bottom">Change at Week 102<hr/></td><td align="center" valign="bottom">-1.0 (7.9)<hr/></td><td align="center" valign="bottom">-0.1 (8.1)<hr/></td><td align="center" valign="bottom">-1.5 (8.1)<hr/></td><td align="center" valign="bottom">-1.2 (10.1)<hr/></td></tr><tr><td align="left"><italic>P</italic>&#x02009;vs PBO + MET</td><td align="center">&#x000a0;</td><td align="center">0.6605</td><td align="center">0.2140</td><td align="center">0.1075</td></tr></tbody></table><table-wrap-foot><p>Data are means (SD) at baseline or mean changes (SD) from baseline at week 102
including data after rescue unless noted. n is the number of treated patients
with non-missing baseline and Week 102 values for the specific test.
<sup><bold>a</bold></sup>Excluding data after rescue. Abbreviations:
<italic>SD</italic>&#x02009;standard deviation, <italic>SE</italic>&#x02009;standard error,
<italic>PBO</italic>&#x02009;placebo, <italic>MET</italic> metformin,
<italic>DAPA</italic>&#x02009;dapagliflozin.</p></table-wrap-foot></table-wrap></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1741-7015/11/193/prepub">http://www.biomedcentral.com/1741-7015/11/193/prepub</ext-link></p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>CJ</given-names></name><name><surname>Gross</surname><given-names>JL</given-names></name><name><surname>Hennicken</surname><given-names>D</given-names></name><name><surname>Iqbal</surname><given-names>N</given-names></name><name><surname>Mansfield</surname><given-names>TA</given-names></name><name><surname>List</surname><given-names>JF</given-names></name><article-title>Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with
metformin: a randomized, double-blind, placebo-controlled 102-week trial</article-title><source>BMC Medicine</source><year>2013</year><volume>11</volume><fpage>43</fpage><pub-id pub-id-type="doi">10.1186/1741-7015-11-43</pub-id><pub-id pub-id-type="pmid">23425012</pub-id></mixed-citation></ref></ref-list></back></article>